baber/WOPTO huggingface dataset:
Patent ES-2395061-B2 (ES)
Title: Empleo de un catalizador heterogéneo ácido en la síntesis de cetonas alfa,beta-insaturadas a partir de aldehídos y cetonas.
Inventor: DURAN VALLE CARLOS JAVIER
IPC: B01J21/18
Filed: 2011-06-22
Granted: 2013-08-05
Abstract: Empleo de un catalizador heterogéneo ácido en la síntesis de cetonas {al},{be}-insaturadas a partir de aldehídos y cetonas.#La invención se refiere a un procedimiento para la obtención de cetonas {al},{be}-insaturadas a partir de aldehídos y cetonas, usando como catalizador heterogéneo un carbón de carácter ácido, preparado con ácido sulfúrico, según se describe en la patente española ES2275415. El uso de catalizadores en esta reacción disminuye considerablemente el tiempo de reacción, permite llevar a cabo el proceso en condiciones suaves de temperatura, aumentando así la pureza de los productos finales y disminuyendo la producción de compuestos indeseados y, por lo tanto, el coste global del proceso.
Patent ES-2385988-B2 (ES)
Title: Composición farmacéutica sólida estable y procedimientos de preparación correspondientes
Inventor: WAGNER LASZLO
IPC: A61K9/20
Filed: 2009-09-30
Granted: 2013-12-11
Abstract: Composición farmacéutica sólida estable y procedimientos de preparación correspondientes. Composición farmacéutica sólida estable que contiene amlodipina o sus sales farmacéuticas aceptables y bisoprolol o sus sales farmacéuticas aceptables así como excipientes farmacéuticamente aceptados, envasada en un envase impermeable a la humedad y que comprende menos de 0,5% del compuesto de la fórmula (3) sobre la base del peso de los principios activos.
Patent ES-2564566-B2 (ES)
Title: Nuevo sistema de filtración basado en el empleo de arena verde de manganeso para la eliminación del radio contenido en agua
Inventor: BAEZA ESPASA ANTONIO
IPC: C02F1/28
Filed: 2014-09-22
Granted: 2016-11-14
Abstract: Nuevo sistema de filtración basado en el empleo de arena verde de manganeso para la eliminación del radio contenido en agua.#La presente invención se refiere a un sistema de filtración para la eliminación del radio contenido en agua basado en un lecho filtrante caracterizado porque comprende i) una capa superior formada por arena de sílice, ii) una capa intermedia formada por arena verde de manganeso, y iii) una capa inferior formada por arena de sílice. Asimismo, contempla un método para la eliminación del Ra contenido en agua, basado en el empleo de dicho sistema de filtración, que a su vez permite la desadsorción del radio detenido tras la filtración y la regeneración y reutilización de dicho sistema filtrante.
Patent AU-2000280280-B2 (AU)
Title: Process for reducing pollutants from the exhaust of a diesel engine
Inventor: DUNCAN DAVID
IPC: C09K23/52
Filed: 2000-10-17
Granted: 2004-12-23
Abstract: This invention relates to a process for reducing the level of pollutants in the exhaust of a diesel engine, comprising: operating said diesel engine using as the fuel a water-diesel fuel emulsion; and contacting the exhaust gas from said diesel engine with an oxidation catalyst.
Patent AU-2001230125-B2 (AU)
Title: Synchronous generator
Inventor: WOBBEN ALOYS
IPC: H02M1/12
Filed: 2000-12-15
Granted: 2004-08-26
Abstract: A slowly rotating synchronous generator (ring generator) for a wind power installation, the generator having a rotor and a stator surrounding the rotor, and the stator having at least one three-phase current winding on which a capacitive current is impressed, and the generator having a part of the exciter power of the generator produced by the stator.
Patent AU-2001248529-B2 (AU)
Title: Stabilised radiopharmaceutical compositions
Inventor: EDWARDS DAVID
IPC: A61K51/12
Filed: 2001-04-11
Granted: 2007-02-01
Abstract: The present invention relates to stabilized <SUP>99m</SUP>Tc radiopharmaceutical compositions, which include both a radioprotectant and one or more antimicrobial preservative(s), and hence have an extended lifetime of use. The radioprotectant is ascorbic acid, para-aminobenzoic acid, gentisic acid or a salt thereof with a biocompatible cation, and the antimicrobial preservative is one or more compound from the paraben series of preservatives. The invention is particularly useful for cationic, lipophilic <SUP>99m</SUP>Tc heart imaging agents such as Myoview(TM).
Patent AU-2002214031-B2 (AU)
Title: System for withdrawing blood
Inventor: DECK FRANK
IPC: G01N33/48
Filed: 2001-10-30
Granted: 2005-04-21
Abstract: The drive unit has a plunger (10) which is movable from a non-operating to a penetration position. The penetration unit (20) contains the lancet (30) with a needle which is inside the penetration unit in the plunger's non-operating position, and which is at least partly extruded from an outlet (41) in the penetration unit by the plunger. The plunger has a holder part (11) held by the holder (32a,b) on the lancet.
Patent AU-2002217245-B2 (AU)
Title: Rocker-connection connector
Inventor: HOUDE CLAUDE
IPC: H01R4/48
Filed: 2001-12-11
Granted: 2006-07-20
Abstract: The invention concerns a connecting device for electrical conductors comprising two cage-spring type connectors (2, 3) fixed to at least a conductive terminal (1), characterised in that it is based on a single control member mobile between two positions respectively corresponding to the opening of the two connectors (2, 3) and capable of taking a stable position corresponding to the simultaneous closure of said connectors (2, 3). Said control member consists of a rotary rocker made of insulating material, provided with an arm for manipulating (7) the connectors (2, 3) arranged inactive between the latter which are superimposed in mirror arrangement, said arm (7) being then in contact with rounded portions of the distal spring leaves (2, 3) of their planar portions fixed to the terminal (1), and urging one or the other of said spring leaves in the rotational direction imparted to the arm (7).
Patent AU-2002230307-B2 (AU)
Title: Wave-powered generator device
Inventor: ANDERSEN EGIL
IPC: F03B13/14
Filed: 2002-01-31
Granted: 2004-09-23
Abstract: A wave power station device ( 1 ) of the kind wherein the waves flow up a ramp ( 12 ) and wherein the ramp ( 12 ) is provided with fixed openings ( 17 ), the openings ( 17 ) being arranged in such a way that water flowing up the ramp ( 12 ) will flow down through the openings ( 17 ) to an insignificant degree, whereas water flowing down the ramp ( 12 ) will essentially flow down through the openings ( 17 ).
Patent AU-2002247696-B2 (AU)
Title: Use of supersecretable peptides in processes for their production and for parallel improvement of the exported forms of one or more other polypeptides
Inventor: HABERMANN PAUL
IPC: C12N1/19
Filed: 2002-02-08
Granted: 2006-10-12
Abstract: The invention relates to an expression cassette of the form Px-Sx-Bn-(ZR)-transport peptide-(Z1Z2)-protein(Y)-(Z1Z2)-protein (Ym)-T; wherein the expression cassette codes for a transport peptide linked via a sequence Z1Z2 to a second protein which in turn is linked via Z1Z2 to a protein Y1 which either corresponds to Y or can be different from Y and the transport peptide improves the rate of secretion and Y and/or Ym where Px is any promoter DNA sequence selected in such a way that optimal yields of the protein of interest become obtainable; Sx is any DNA which, accordingly, encodes any signal or leader sequence which allows optimal yields; Bn is 1-15 genetically encodable amino acids or a chemical bond; Z is the codon of an amino acid selected from the group comprising Lys and Arg; Z1 is the codon of an amino acid selected from the group comprising Lys and Arg; Z2 is the codon of an amino acid selected from the group comprising Lys and Arg; protein Ym is a DNA sequence encoding any protein which can be produced and secreted by yeast (m=1-5) or is a chemical bon (m=0); R is an argine codon; transport peptide is a DNA sequence encoding a peptide which can be transported efficiently and which can pass membranes; protein Y is a DNA sequence encoding any protein which can be produced and secreted by yeast and whose biological activity, when Ym is not a chemical bond, is not impaired by a basic dipeptide extension or allows degradation of the extension by carboxypeptidases; T is an untranslated DNA sequence advantageous to the expression, and to processes for the production and use thereof.
Patent AU-2002256685-B2 (AU)
Title: Pyrrolidine ester derivatives with oxytocin modulating acitvity
Inventor: SCHWARZ MATTHIAS
IPC: A61K31/4439
Filed: 2002-03-19
Granted: 2008-01-24
Abstract: The present invention is related to the use of pyrrolidine esters of formula (I) for the treatment and/or prevention of premature labor, premature birth and dysmenorrhea. In particular, the present invention is related to the use of pyrrolidine esters of formula (I) to modulate, notably to antagonise the oxytocin receptor. The present invention is furthermore related to novel pyrrolidine esters. X is selected from the group consisting of CR 6 R 7 , NOR 6 , NNR 6 R 7 ; R is selected from the group comprising or consisting of C 1 -C 6  alkyl, C 2 -C 6  alkenyl, C 2 -C 6  alkynyl, saturated or unsaturated 3-8-membered cycloalkyl which may contain 1 to 3 heteroatoms selected of N, O, S, aryl, heteroaryl, C 1 -C 6 -alkyl aryl, C 1 -C 6 -alkyl heteroaryl. R 1  is selected from the group comprising or consisting of C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, aryl, heteroaryl, 3-8-membered cycloalkyl, acyl, C 1 -C 6 -alkyl aryl, C 1 -C 6 -alkyl heteroaryl, said cycloalkyl or aryl or heteroaryl groups may be fused with 1-2 further cycloalkyl or aryl or heteroaryl group.
Patent AU-2002325233-B2 (AU)
Title: Process to prepare a base oil from slack-wax
Inventor: BENARD GERARD
IPC: C10G67/04
Filed: 2002-06-07
Granted: 2007-08-02
Abstract: A process to prepare a base oil starting from a slack wax containing feedstock by (a) contacting the feedstock in the presence of hydrogen with a sulphided hydrodesulphurisation catalyst having nickel and tungsten on an acid amorphous silica-alumina carrier and (b) performing a pour point reducing step on the effluent of step (a) to obtain the base oil.
Patent AU-2002347688-B2 (AU)
Title: A method for preparing a sensitised emulsion explosive
Inventor: VESTRE JAN
IPC: F42D1/10
Filed: 2002-12-20
Granted: 2007-06-07
Abstract: This invention relates to a method for rapid chemical gassing of an emulsion explosive without having toxic nitrogen oxides in the finished emulsion explosive product, when nitrite is used as the gassing component. Urea acts as a gassing accelerator and urea are added in the water lubrication solution or in both the water lubrication solution and in the gassing component. To achieve rapid gassing of an emulsion explosive, the emulsion is prepared at a pH in the range of 0-3, by using an organic acid having at least 3 carbon atoms.
Patent AU-2003231757-B2 (AU)
Title: Polymer compositions containing a macrocyclic triene compound
Inventor: SHULZE JOHN E
IPC: A61F2/90
Filed: 2003-04-24
Granted: 2009-07-09
Abstract: An endovascular stent for placement at a vascular injury site for inhibiting restenosis at the site is provided, the stent comprising a structural member or body formed of one or more filaments and carried on the stent-body filament(s), a drug-release coating composed of (i) 20-70 weight percent polymer substrate and (ii) 30-80 weight percent of a macrocyclic triene immunosuppressive compound, wherein the coating substrate comprises a polylactic acid polymer.
Patent AU-2003238333-B2 (AU)
Title: Administration device comprising a priming function
Inventor: KIRCHHOFER FRITZ
IPC: A61M5/315
Filed: 2003-07-08
Granted: 2006-02-02
Abstract: An administering apparatus for administering a fluid product, including a casing, a reservoir for the product, a driven device which acts on the product contained in the reservoir to deliver the product, and a drive device which acts on the driven device and performs a delivery stroke in a drive direction from a delivery position up to a delivery stopper to deliver a product dosage to be administered, wherein a priming stopper is provided for the drive device and limits a priming stroke of the drive device, which serves to bleed, in the drive direction, wherein the priming stroke is axially shorter than a maximum delivery stroke, and wherein the drive device can be moved in the drive direction from a priming position up to the priming stopper and transversely to the drive direction as far as the delivery position.
Patent AU-2003288303-B2 (AU)
Title: Method, device, base station and system for direct uplink access in a mobile communications network
Inventor: RINNE MIKKO
IPC: H04W72/14
Filed: 2003-12-18
Granted: 2008-09-04
Abstract: The invention relates to a method between a communications device ( 110 ) and a communications network, which communications network generally provides at least a direct cell access mechanism and an alternative cell access mechanism for the communications device for uplink access to the communications network. The method comprises determining by the communications network and indicating ( 230 ) to the communications device ( 110 ) whether the direct cell access mechanism can at a given time be provided. This being the case, the communications device can directly start sending user data ( 150 ) on a traffic channel. In a situation in which the direct cell access cannot be provided, it is indicated to the communications device that the alternative cell access mechanism should be used.
Patent AU-2004266199-B2 (AU)
Title: Novel fungal proteins and nucleic acids encoding same
Inventor: MONOD MICHEL
IPC: A61K38/00
Filed: 2004-08-25
Granted: 2010-09-16
Abstract: Disclosed herein are fungal nucleic acid sequences that encode novel dipetidyl peptidase IV (DPPIV) polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The aminopeptidase polypeptides, referred to herein as DPPIV proteins of the invention are useful in a variety of medical, research, and commercial applications.
Patent AU-2005202557-B2 (AU)
Title: Optical film capable of absorbing ultraviolet light
Inventor: HSU LUNG-LIN
IPC: C08J7/04
Filed: 2005-06-10
Granted: 2011-09-01
Abstract: OPTICAL FILM CAPABLE OF ABSORBING ULTRAVIOLET LIGHT The invention pertains to an optical film comprising a substrate, characterized in 5 that at least one of the surfaces of the substrate has a coating capable of absorbing UV light. The inventive optical film possesses good weatherability and is capable of absorbing UV light.
Patent AU-2005202770-B2 (AU)
Title: Stabilization of fresh mozzarella cheese using fermented whey
Inventor: ZHENG ZUOXING
IPC: A23C19/068
Filed: 2005-06-24
Granted: 2010-03-25
Abstract: The invention is directed to a fermented and clarified nisin-containing whey and a method of making that can be used to produce a stabilized food product by adding, for example, to the pack water of fresh mozzarella cheese. The resulting stabilized food product retards or limits below detection levels the growth of toxins from pathogenic bacterial contaminants when the nisin-containing whey is added in amounts between about 10 to about 30% to the food product. The stabilized food product improves the safety of the food by retarding the growth of Listeria monocytogenes and improves the shelf life of the product by retarding the growth of gas forming bacteria such as bacteria from the Leuconostoc species. <IMAGE>
Patent AU-2005219367-B2 (AU)
Title: Impact attenuator for vehicle and method
Inventor: CARSSON ARNE
IPC: E01F15/14
Filed: 2005-03-04
Granted: 2008-05-01
Abstract: An impact attenuator, which is arranged to be flexible longitudinally as well as sideways, has a rear part with two wheels, an attenuating part, a front part with two pivot wheels, and a coupling part for connection to a vehicle. The coupling part has a damper for dampening part of the force during a collision against the impact attenuator. During a minor collision against the impact attenuator the collision force is mainly absorbed by the damper. The damper regains after a collision its original position and the impact attenuator can remain operative. During a larger collision against the impact attenuator, the collision forces are also absorbed by the attenuating part.
Patent AU-2006204103-B2 (AU)
Title: Treatment of drug-resistant proliferative disorders
Inventor: RAMANA REDDY M V
IPC: C07C317/00
Filed: 2006-01-04
Granted: 2011-11-24
Abstract: α,β-Unsaturated sulfones, sulfoxides and sulfonamides according to Formula I: wherein Ar, Ar, X, n, * and R are as defined herein are useful for the treatment of proliferative disorders which are resistant to treatment by ATP-competitive kinase inhibitors.
Patent AU-2006216542-B2 (AU)
Title: Methods for enhancing antibody-induced cell lysis and treating cancer
Inventor: WEINER GEORGE
IPC: A61K39/395
Filed: 2006-09-15
Granted: 2009-04-30
Abstract: The invention relates to methods and products for treating cancer. In particular the invention relates to combinations of nucleic acids and antibodies for the treatment and prevention of cancer. The invention also relates to diagnostic methods for screening cancer cells.
Patent AU-2006216792-B2 (AU)
Title: Irritant-free gel compositions
Inventor: GRANEY BERNARD
IPC: F41H9/10
Filed: 2006-02-22
Granted: 2011-03-17
Abstract: Irritant-free gel compositions according to the present invention include less than 5 parts by weight of one or more marking agents, 0.25-2 parts by weight of a thickening agent; and 30-90 parts by weight water. The thickening agent is typically a vegetable gum. In some embodiments, the compositions may additionally include 20-60 parts by weight of at least one water-miscible solvent, such as monohydric alcohols, polyhydric alcohols and mixtures thereof. The water-miscible solvent may be methyl alcohol, ethyl alcohol, isopropyl alcohol, n-propyl alcohol, ethylene glycol, propylene glycol or a mixture thereof, and preferably a mixture of isopropyl alcohol and propylene glycol.
Patent AU-2006225065-B2 (AU)
Title: Control of sucking lice
Inventor: COOPER DAVID JOHN
IPC: A61P33/14
Filed: 2006-03-07
Granted: 2012-08-16
Abstract: The invention describes the use of a microbial preparation of one or more bacteria, for example of the genus Bacillus in the manufacture of a formulation as a medicament for the treatment and prevention of infestation of sucking lice from the order Phthiraptera, Anoplura, Rhynchophthirina and/or Pediculidae. The medicament can be applied to plumage, pelage or hair to control sucking lice.
Patent AU-2006255515-B2 (AU)
Title: Qubit state copying
Inventor: BERKLEY ANDREW J
IPC: H01L39/22
Filed: 2006-04-26
Granted: 2011-09-15
Abstract: Systems and methods for copying the classical state of a source qubit to a target qubit are provided. These techniques may be used to read out the states of an array of qubits.
Patent AU-2006306398-B2 (AU)
Title: Material compositions for sensors for determination of chemical species at trace concentrations and method of using sensors
Inventor: CECCONIE THEODORE J
IPC: G01N21/78
Filed: 2006-10-20
Granted: 2012-08-30
Abstract: A method of quantitatively measuring the concentration of a chemical species in a sample solution with a sensor film. A hydrogel sensor film is prepared having a chemical composition comprising an indicator that changes its optical property in the ultra-violet, visible or near-infrared spectral range upon being exposed to the chemical species in the sample solution. The film is exposed to a fixed amount of the sample solution. The concentration of the chemical species in the sample solution is quantified using the average absorbance measured from the sensor film.
Patent AU-2006330816-B2 (AU)
Title: Prosthesis deployment system
Inventor: OSBORNE THOMAS A
IPC: A61F2/84
Filed: 2006-12-22
Granted: 2012-05-24
Abstract: A trigger wire release mechanism is disclosed that includes a control member for selectively releasing a trigger wire (22, 44) from a prosthesis retaining device. The control member includes an elongate body member (36) and a guide member (24, 25, 93, 94) slidably disposed on the elongate body member. The trigger wire 1 (22, 44) includes a distal end coupled to the prosthesis retaining device and a proximal end coupled to the guide member. The guide member (24, 25, 93, 94) can lbe moved from a distal end of the elongate body (36) to a proximal end of the elongate body, thereby disengaging the trigger wire (22, 44) from the retaining device. The control member may include a locking mechanism (120) for limiting the axial position of the guide member (24, 25, 93, 94) along the elongate body member (36). A prosthesis control member (81) is also disclosed. The prosthesis control member (81) is adapted to control the position of the prosthesis during deployment.
Patent AU-2007203066-B2 (AU)
Title: Barrier film products and processes
Inventor: MORLEY RONALD EDWARD
IPC: B65D53/04
Filed: 2007-06-29
Granted: 2014-01-30
Abstract: A container is formed from; (a) an exterior continuous structure providing a peripheral wall and an end wall for 5 forming a base of the container extending transversely to the peripheral wall, and (b) an interior structure provided by a preformed laminate having a first layer of plastics material compatible with the product, a substantially oxygen impervious layer and a further layer of weldable plastics material, (c) the exterior structure being of plastics material welded to the further layer of the interior structure in a moulding process, 10 which also causes the laminate to be formed to provide an overlapping relationship at a junction between the end wall and the peripheral wall, and (d) the plastics material associated with one of the layers of the laminate at the end wall bonded to an adjacent layer of plastics material of the laminate of the peripheral wall in the region of the junction. (2 . .......... 56 -46 !50 FIGURE 5B
Patent AU-2007205224-B2 (AU)
Title: Treatment modalities for autoimmune diseases
Inventor: BLAND JEFFREY S
IPC: A61K31/12
Filed: 2007-01-04
Granted: 2013-03-28
Abstract: Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.
Patent AU-2007207496-B2 (AU)
Title: Polyurethanes for Osteoimplants
Inventor: SHIMP LAWRENCE A
IPC: C08G63/48
Filed: 2007-01-19
Granted: 2013-09-26
Abstract: Biological-based polyurethanes and methods of making the same. The polyurethanes are formed by reacting a biodegradable polyisocyanate (such as lysine diisocyanate) with an optionally hydroxylated biomolecule to form polyurethane. The polymers formed may be combined with ceramic and/or bone particles to form a composite, which may be used as an osteoimplant.
Patent AU-2007207602-B2 (AU)
Title: Self expanding stent
Inventor: HARTLEY DAVID ERNEST
IPC: A61F2/86
Filed: 2007-01-17
Granted: 2012-08-23
Abstract: A self expanding stent (10) formed from a resilient wire. The resilient wire comprises a zig zag form including an odd number of struts (12) such as seven struts and a bend (14) between each strut. There is first loop (18) of the resilient wire at the terminal end of a first strut and a second loop (18) of the resilient wire at the terminal end of a last strut. The stent as formed is substantially planar but in use is formed into a substantially cylindrical form (20) by being stitched onto a tubular body of a biocompatible graft material with at least the first strut and the last strut overlapping.